"Estrogen-related dementia" refers to cognitive decline linked to reduced estrogen levels, primarily in postmenopausal women. Estrogen plays a critical role in brain functions like memory and cognition, potentially safeguarding against Alzheimer's disease and other forms of dementia by supporting synaptic activity, reducing beta-amyloid plaques, and promoting neuronal survival.
Following menopause, declining estrogen levels may heighten the risk of cognitive impairment. Hormone replacement therapy (HRT) has been explored as a potential strategy to counteract this decline, though its benefits and risks remain under scrutiny. A deeper understanding of how estrogen influences dementia can guide the development of targeted therapies aimed at preserving cognitive health, particularly in aging women.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China